The Company considers uranium mineralization with assay results of greater than 1.0 weight % U 3 O 8 as "high grade" and ...

Announced extraordinary 86% overall survival at 9 months in first-line pancreatic cancer patients treated with atebimetinib + mGnP - - Raised $225 million of financing, including $25 million private ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO ...

Vitale plans to be on the call for the Dick Vitale Invitational, which pits No. 6 Duke vs. Texas in Charlotte’s Spectrum ...

HD 10 is currently represented by Brannan’s father, Rep. Chuck Brannan, who is term-limited in 2026. A total of 230 Mayors, ...

The third quarter was truly transformational for Immuneering (IMRX). We announced extraordinary overall survival data from our ongoing Phase 2a ...

Discovery of uranium mineralization in ideal geological setting, supported by regional radiometric anomaly, confirms large ...

Q2 2026 Earnings Call Transcript November 10, 2025 Immunovant, Inc. misses on earnings expectations. Reported EPS is ...

The oropharyngeal cancer market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as PDS Biotechnology's Versamune HPV, Inovio ...

The Navy provided a summary to the EPA on Oct. 23 of this year ... In 2023, the Navy unearthed two radioactive objects there. Early last year, the Navy, for the first time, acknowledged what Bay Area ...